Table 3.

Acute side effects during treatment with HT and concurrent chemotherapy

Common Toxicity Criteria (CTC)	All patients	Recurrence Treatment Group	Primary Treatment Group
Radiotherapy	n = 26	n = 12	n = 14
Radiodermatitis °1	14 (53%)	6 (50%)	8 (57%)
Radiodermatitis °2	6 (23%)	4 (33%)	2 (14%)
Radiodermatitis °3	6 (23%)	2 (16.7%)	4 (28%)
Dysphagia °1	10 (%)	5 (42%)	5 (36%)
Lymphedema °3	3 (11%)	4 (33%)	1 (7%)
Fatigue	12 (46%)	5 (42%)	7 (50%)
Chemotherapy	n = 11	n = 9	n = 2
Leucopenia °1	6 (55%)	5 (55%)	1 (50%)
Leucopenia 2	5 (42%)	4 (44%)	1 (50%)
Anemia 1	6 (55%)	6 (67%)	−
Anemia 2	3 (27%)	2 (22%)	1 (50%)
Anemia 3	1 (9%)	−	1 (50%)
Hand-foot-syndrome	2 (18%)	2 (22%)	−